Asian Pacific Journal of Cancer Prevention

  • 제13권7호
  • /
  • Pages.3357-3360
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Follow-Up Study of Survival of Patients with Advanced Cancer in a Hospice Setting

  • Wang, Yu-Mei (Department of Palliative Care Ward, Shengjing Hospital of China Medical University) ;
  • Guo, Hai-Qiang (Department of Public Health, China Medical University)
  • 발행 : 2012.07.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: This study was to present the survival of advanced cancer patients and explore the influence of various factors on survival time as well as survival rate. The results provide guidelines for clinical practice of cancer treatment. Methods: Follow-up of 674 advanced cancer patients was performed in a hospice. The median survival time and survival rate were calculated, and survival analysis was carried out. Results: The median survival time of all patients dying from cancer was 12.0 months and the average survival time was 25.1 months. The 1-year cumulative survival rate was $0.518{\pm}0.020$ and the 5-year cumulative survival rate was $0.088{\pm}0.012$. The following factors showed significant impacts on survival rate: gender, age, primary diagnosis, surgery and the time when pain appeared. Conclusions: The survival time of patients with advanced cancer was relatively short. Major approaches to extend the survival time include early detection, early diagnosis, effective surgical treatment, pain control, reasonable supply of nutrients and multiple interventions.

키워드

참고문헌

  1. Aberle DR, Brown K (2008). Lung cancer screening with CT. Clin Chest Med, 29, 1-14. https://doi.org/10.1016/j.ccm.2007.12.001
  2. Chen WQ (2009). Estimation of cancer incidence and mortality in China in 2004-2005. Zhonghua Zhong Liu Za Zhi, 31, 664-8.
  3. Coche E (2008). Screening for lung cancer with low-dose CT. JBR-BTR, 91, 1-5.
  4. Coleman RE, Winter MC, Cameron D, et al (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. Br J Cancer, 102, 1099-105. https://doi.org/10.1038/sj.bjc.6605604
  5. Cook IG, Dummer TJ (2004). Changing health in China: reevaluating the epidemiological transition model. Health Policy, 67, 329-43. https://doi.org/10.1016/j.healthpol.2003.07.005
  6. Cunningham AJ, Edmonds CV, Jenkins GP, et al (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology, 7, 508-17. https://doi.org/10.1002/(SICI)1099-1611(199811/12)7:6<508::AID-PON376>3.0.CO;2-7
  7. DeAngelis LM, Seiferheld W, Schold SC, et al (2002). Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol, 20, 4643-8. https://doi.org/10.1200/JCO.2002.11.013
  8. Glare P, Sinclair C, Downing M, et al (2008). Predicting survival in patients with advanced disease. Eur J Cancer, 44, 1146-56. https://doi.org/10.1016/j.ejca.2008.02.030
  9. Guo P, Huang ZL, Yu P, Li K (2012). Trends in cancer mortality in China: an update. Ann Oncol.
  10. Henry C (2011). National End of Life Care Programme: progress and future directions. Int J Palliat Nurs, 17, 108-112. https://doi.org/10.12968/ijpn.2011.17.3.108
  11. Morin D, Saint-Laurent L, Bresse MP, et al (2007). The benefits of a palliative care network: a case study in Quebec, Canada. Int J Palliat Nurs, 13, 190-6. https://doi.org/10.12968/ijpn.2007.13.4.23488
  12. O'Brien S, Hatfield AR, Craig PI, Williams SP (1995). A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut, 36, 618-21. https://doi.org/10.1136/gut.36.4.618
  13. Peters C, Lotzerich H, Niemeir B, et al (1995). Exercise, cancer and the immune response of monocytes. Anticancer Res, 15, 175-9.
  14. Rhodes AR (1995). Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer, 75, 613-36. https://doi.org/10.1002/1097-0142(19950115)75:2+<613::AID-CNCR2820751403>3.0.CO;2-G
  15. Smith RA, Cokkinides V, Eyre HJ (2006). American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin, 56, 11-25; quiz 49-50. https://doi.org/10.3322/canjclin.56.1.11
  16. Smith R, Williams N, Thomas K (2007). The American way of death. Health Serv J, 117, 28-9.
  17. Wang D, Zheng W, Wang SM, et al (2012). Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer, 64, 48-56. https://doi.org/10.1080/01635581.2012.630166
  18. Zheng H, Tong L, Hu Y, et al (2011). [Prognostic factors in 408 elderly lung cancer patients more than 70 years old]. Zhongguo Fei Ai Za Zhi, 14, 502-6.